Optical Coherence Tomography (OCT) Reference Data Collection Study (S-2015-1)



Status:Recruiting
Conditions:Ocular
Therapuetic Areas:Ophthalmology
Healthy:No
Age Range:18 - 90
Updated:2/24/2019
Start Date:June 2016
End Date:December 2019
Contact:Thomas Schulz, PhD
Email:thomas.schulz@heidelbergengineering.com
Phone:+49 6221 64630

Use our guide to learn which trials are right for you!

This prospective, single-arm clinical multicenter study intends to measure normal structural
parameters of the optic nerve head, the peripapillary retinal nerve fiber layer, and the
macula using the Heidelberg Spectralis OCT device. This study is conducted in
African-American descent volunteers. The main goal of the study is to provide the range of
these structural parameters in normal eyes.

This prospective, single-arm clinical multicenter study intends to measure normal structural
parameters of the optic nerve head, the peripapillary retinal nerve fiber layer, and the
macula using the Heidelberg Spectralis OCT device. This study is conducted in
African-American descent volunteers. The main goal of the study is to provide the range of
these structural parameters in normal eyes. The study will include at least 240 normal
volunteers; up to 10 study sites will recruit subjects. Overall an approximately equal age
distribution from 18 to 90 years and an approximately equal number of females and males will
be enrolled (approximately 40-60% females in each age group). All subjects will undergo
Spectralis OCT imaging, biometric and ophthalmoscopic examination, disc photography and
visual field testing in one single visit, if possible. Repeated perimetry or Spectralis scans
may be performed at a second visit within 30 days of the initial visit. All examinations
performed on the subjects are non-significant risk procedures.

Inclusion Criteria:

- Able and willing to undergo the test procedures, give consent, and to follow
instructions.

- Signed informed consent

- Age ≥18 to 90.

- Healthy eye without prior intraocular surgery (except cataract surgery and Laser in
Situ Keratomileusis) and without clinically significant vitreal, retinal or choroidal
diseases, clinically significant diabetic retinopathy (subject may have diabetes), or
disease of the optic nerve. Small drusen are acceptable in older subjects.

- Black or African-American decent (self-reported)

- Negative history of glaucoma (not including family history)

- Intraocular pressure ≤21mmHg.

- Best corrected visual acuity ≥20/40.

- Refraction between +6 and -6 diopters and astigmatism ≤ 2 diopters.

- Axial length ≤ 26.0 mm (by optical biometry)

- Normal visual field with Glaucoma Hemifield Test and Mean Deviation within normal
limits or not abnormal visual field by judgment of the ophthalmologist / optometrist

- Clinically normal appearance of the optic disc, with normal appearing neuroretinal rim
with respect to color and shape. The optic disc is examined ophthalmoscopically and by
evaluation of stereo photographs.

- If both eyes are eligible, both eyes enter the study.

Exclusion Criteria:

- Vulnerable subjects (as defined in ISO 14155 GCP) with the exception of employees of
the site, and, if applicable, students of the respective university. Staff that is
listed on the delegation form are excluded from participation.

- Subjects unable to read or write

- Unreliable visual field. The reliability indices should be used as guide as well as
the perimetrist's notes.

- Unusable disc stereo photos.

- Inability to undergo the tests.

- Insufficient quality of Spectralis OCT images (this is not determined until after
Spectralis OCT examination, and is an unusual circumstance).

Minimum requirements are:

- Retina completely included in image frame,

- Quality Score ≥ 20 in the stored ART mean images, and

- For ONH-R scan: Center position error ≤ 100 μm.
We found this trial at
8
sites
New York, New York 10036
Principal Investigator: Mitch Dul, OD
?
mi
from
New York, NY
Click here to add this to my saved trials
Chicago, Illinois 60616
Principal Investigator: Michael Chaglasian, OD
?
mi
from
Chicago, IL
Click here to add this to my saved trials
Jamaica, New York 11425
Principal Investigator: Murray Fingeret, OD
?
mi
from
Jamaica, NY
Click here to add this to my saved trials
9500 Gilman Dr
La Jolla, California 92093
(858) 534-2230
Principal Investigator: Linda Zangwill, MD
The University of California, San Diego UC San Diego is an academic powerhouse and economic...
?
mi
from
La Jolla, CA
Click here to add this to my saved trials
Mount Dora, Florida 32757
Principal Investigator: Gregory Panzo, MD
?
mi
from
Mount Dora, FL
Click here to add this to my saved trials
Philadelphia, Pennsylvania 19107
Principal Investigator: Jay Katz, MD
?
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Santa Monica, California 90404
Principal Investigator: Harmohina Bagga, MD
?
mi
from
Santa Monica, CA
Click here to add this to my saved trials
Valley Stream, New York 11581
Principal Investigator: Gerard D'Aversa, MD
?
mi
from
Valley Stream, NY
Click here to add this to my saved trials